Literature DB >> 8904417

Genome macrorestriction analysis of sequential Pseudomonas aeruginosa isolates from bronchiectasis patients without cystic fibrosis.

S W Hla1, K P Hui, W C Tan, B Ho.   

Abstract

The respiratory tracts of bronchiectasis patients may be persistently colonized with Pseudomonas aeruginosa, despite intensive chemotherapy. The organism may undergo phenotypic changes in these patients, providing misleading typing results by conventional methods. We prospectively studied eight bronchiectasis patients without cystic fibrosis over a period of 1 year. A high microbial load of P. aeruginosa was found in 70% of sputum samples collected. Of these, 55 sequential P. aeruginosa isolates were characterized by a genotyping method, pulsed-field gel electrophoresis, to overcome the problem of differentiating the P. aeruginosa strains during chemotherapy. Genome macrorestriction fingerprinting patterns were analyzed after digestion with XbaI restriction endonuclease. Of the eight patients, six harbored a single dominant strain of P. aeruginosa, with an intrapatient macrorestriction similarity pattern range of 96 to 100%. The other two patients were infected with mixed bacterial isolates including P. aeruginosa. However, diversity was observed in the P. aeruginosa isolates from all eight patients, with a relatedness of only 55 to 65%. The study further strengthens the fact that pulsed-field gel electrophoresis can be used efficiently and effectively to differentiate P. aeruginosa strains in bronchiectasis patients without cystic fibrosis.

Entities:  

Mesh:

Year:  1996        PMID: 8904417      PMCID: PMC228849          DOI: 10.1128/jcm.34.3.575-578.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis.

Authors:  D P Speert; S W Farmer; M E Campbell; J M Musser; R K Selander; S Kuo
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

2.  Use of low-frequency-cleavage restriction endonucleases for DNA analysis in epidemiological investigations of nosocomial bacterial infections.

Authors:  A Allardet-Servent; N Bouziges; M J Carles-Nurit; G Bourg; A Gouby; M Ramuz
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

3.  Use of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa.

Authors:  D P Speert; M E Campbell; S W Farmer; K Volpel; A M Joffe; W Paranchych
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

Review 4.  Bronchiectasis: update of an orphan disease.

Authors:  A F Barker; E J Bardana
Journal:  Am Rev Respir Dis       Date:  1988-04

5.  Pseudomonas aeruginosa mucoid strain. Its significance in adult chest diseases.

Authors:  M Rivera; M B Nicotra
Journal:  Am Rev Respir Dis       Date:  1982-11

6.  Pseudomonas colonization in cystic fibrosis. A study of 160 patients.

Authors:  L L Kulczycki; T M Murphy; J A Bellanti
Journal:  JAMA       Date:  1978-07-07       Impact factor: 56.272

7.  Significance of Pseudomonas aeruginosa in sputum.

Authors:  M W Burns
Journal:  Br Med J       Date:  1973-08-18

8.  Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains.

Authors:  D Grothues; U Koopmann; H von der Hardt; B Tümmler
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

9.  Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe.

Authors:  C Wolz; G Kiosz; J W Ogle; M L Vasil; U Schaad; K Botzenhart; G Döring
Journal:  Epidemiol Infect       Date:  1989-04       Impact factor: 2.451

10.  Immunopathology of experimental bronchiectasis.

Authors:  J R Lapa e Silva; D Guerreiro; B Noble; L W Poulter; P J Cole
Journal:  Am J Respir Cell Mol Biol       Date:  1989-10       Impact factor: 6.914

View more
  6 in total

1.  DNA banding pattern polymorphism in vancomycin-resistant Enterococcus faecium and criteria for defining strains.

Authors:  D Morrison; N Woodford; S P Barrett; P Sisson; B D Cookson
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

2.  Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections.

Authors:  María D Maciá; David Blanquer; Bernat Togores; Jaume Sauleda; José L Pérez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

3.  High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa.

Authors:  Y H Yau; B Ho; N S Tan; M L Ng; J L Ding
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

4.  Comparative typing of Pseudomonas aeruginosa by random amplification of polymorphic DNA or pulsed-field gel electrophoresis of DNA macrorestriction fragments.

Authors:  N Renders; U Römling; H Verbrugh; A van Belkum
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

5.  Epidemiological analysis of sequential Pseudomonas aeruginosa isolates from chronic bronchiectasis patients without cystic fibrosis.

Authors:  I Pujana; L Gallego; G Martín; F López; J Canduela; R Cisterna
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

6.  Influence of pseudomonas aeruginosa on exacerbation in patients with bronchiectasis.

Authors:  Kiran Chawla; Shashidhar Vishwanath; Mohan K Manu; Bernaitis Lazer
Journal:  J Glob Infect Dis       Date:  2015 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.